BioCentury
ARTICLE | Company News

Amylin other research news

January 15, 1996 8:00 AM UTC

AMLN began studies aimed at making Pramlintide more convenient for patients to use. The company has found that the drug, which is in Phase III studies, can be mixed with one of the most popular insuli...